 Diana Escalona-Vargas
Concepts (158)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetocardiography | 14 | 2025 | 38 | 5.590 |
Why?
| | Magnetoencephalography | 7 | 2025 | 87 | 2.850 |
Why?
| | Pelvic Floor | 6 | 2025 | 52 | 2.450 |
Why?
| | Heart Rate, Fetal | 8 | 2025 | 61 | 2.140 |
Why?
| | Fetal Monitoring | 3 | 2025 | 36 | 2.010 |
Why?
| | Signal Processing, Computer-Assisted | 6 | 2019 | 62 | 1.890 |
Why?
| | Algorithms | 8 | 2020 | 668 | 1.880 |
Why?
| | Fetal Heart | 6 | 2025 | 24 | 1.860 |
Why?
| | Electromyography | 4 | 2021 | 127 | 1.830 |
Why?
| | Pregnancy | 27 | 2025 | 2679 | 1.570 |
Why?
| | Fetus | 8 | 2025 | 195 | 1.380 |
Why?
| | Muscular Diseases | 2 | 2021 | 63 | 1.310 |
Why?
| | Prenatal Diagnosis | 4 | 2022 | 103 | 1.200 |
Why?
| | Electroencephalography | 4 | 2020 | 313 | 1.100 |
Why?
| | Magnetometry | 2 | 2025 | 3 | 0.980 |
Why?
| | Brain | 5 | 2020 | 1325 | 0.980 |
Why?
| | Memory, Short-Term | 1 | 2025 | 73 | 0.910 |
Why?
| | Myography | 4 | 2025 | 14 | 0.830 |
Why?
| | Epilepsy | 1 | 2025 | 187 | 0.780 |
Why?
| | Female | 30 | 2025 | 28262 | 0.700 |
Why?
| | Uterus | 2 | 2018 | 88 | 0.680 |
Why?
| | Buprenorphine | 2 | 2019 | 151 | 0.640 |
Why?
| | Obstetric Labor, Premature | 2 | 2016 | 35 | 0.640 |
Why?
| | Pelvic Floor Disorders | 1 | 2019 | 29 | 0.610 |
Why?
| | Signal-To-Noise Ratio | 5 | 2021 | 20 | 0.600 |
Why?
| | Magnetics | 1 | 2018 | 28 | 0.580 |
Why?
| | Pregnancy Trimester, Third | 3 | 2023 | 58 | 0.570 |
Why?
| | Humans | 33 | 2025 | 52593 | 0.560 |
Why?
| | Magnesium Sulfate | 1 | 2016 | 12 | 0.520 |
Why?
| | Brain Waves | 1 | 2016 | 19 | 0.520 |
Why?
| | Gestational Age | 6 | 2023 | 418 | 0.510 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2016 | 46 | 0.510 |
Why?
| | Uterine Contraction | 1 | 2015 | 31 | 0.490 |
Why?
| | Adult | 14 | 2025 | 14170 | 0.480 |
Why?
| | Neuroprotective Agents | 1 | 2016 | 101 | 0.480 |
Why?
| | Abdomen | 1 | 2015 | 73 | 0.470 |
Why?
| | Anticonvulsants | 1 | 2016 | 134 | 0.470 |
Why?
| | Pilot Projects | 3 | 2025 | 721 | 0.460 |
Why?
| | Opioid-Related Disorders | 2 | 2019 | 400 | 0.450 |
Why?
| | Pregnancy Complications | 2 | 2019 | 400 | 0.450 |
Why?
| | Mathematical Computing | 1 | 2014 | 6 | 0.440 |
Why?
| | Muscle Contraction | 4 | 2025 | 116 | 0.430 |
Why?
| | Heart | 1 | 2016 | 361 | 0.420 |
Why?
| | Computer Simulation | 2 | 2014 | 290 | 0.390 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 591 | 0.390 |
Why?
| | Fetal Movement | 3 | 2018 | 18 | 0.320 |
Why?
| | Postpartum Period | 2 | 2021 | 109 | 0.320 |
Why?
| | Pattern Recognition, Automated | 1 | 2009 | 40 | 0.310 |
Why?
| | Linear Models | 1 | 2009 | 292 | 0.290 |
Why?
| | Reproducibility of Results | 3 | 2018 | 1217 | 0.280 |
Why?
| | Equipment Design | 2 | 2025 | 288 | 0.250 |
Why?
| | Young Adult | 5 | 2025 | 4337 | 0.240 |
Why?
| | Heart Rate | 3 | 2023 | 319 | 0.220 |
Why?
| | Optical Devices | 1 | 2024 | 3 | 0.220 |
Why?
| | Optical Phenomena | 1 | 2024 | 5 | 0.220 |
Why?
| | Feasibility Studies | 2 | 2024 | 403 | 0.220 |
Why?
| | ROC Curve | 2 | 2018 | 254 | 0.220 |
Why?
| | Likelihood Functions | 2 | 2016 | 56 | 0.220 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2024 | 28 | 0.220 |
Why?
| | Fetal Development | 2 | 2023 | 50 | 0.210 |
Why?
| | Arrhythmias, Cardiac | 2 | 2022 | 98 | 0.210 |
Why?
| | Fetal Blood | 1 | 2024 | 79 | 0.210 |
Why?
| | Muscle Strength | 1 | 2024 | 131 | 0.210 |
Why?
| | Diabetes, Gestational | 1 | 2023 | 52 | 0.200 |
Why?
| | Interleukin-6 | 1 | 2024 | 277 | 0.200 |
Why?
| | Muscle, Skeletal | 2 | 2018 | 809 | 0.180 |
Why?
| | Adolescent | 2 | 2025 | 6737 | 0.180 |
Why?
| | Bone Resorption | 1 | 2023 | 302 | 0.180 |
Why?
| | Osteocytes | 1 | 2023 | 226 | 0.170 |
Why?
| | Pregnancy in Diabetics | 1 | 2020 | 25 | 0.160 |
Why?
| | Magnetic Fields | 1 | 2018 | 10 | 0.150 |
Why?
| | Manometry | 1 | 2018 | 22 | 0.150 |
Why?
| | Entropy | 1 | 2018 | 7 | 0.150 |
Why?
| | Vagina | 1 | 2018 | 46 | 0.150 |
Why?
| | Narcotic Antagonists | 1 | 2019 | 139 | 0.150 |
Why?
| | Opiate Substitution Treatment | 1 | 2019 | 102 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 622 | 0.140 |
Why?
| | Action Potentials | 1 | 2018 | 120 | 0.140 |
Why?
| | Cohort Studies | 2 | 2019 | 1553 | 0.140 |
Why?
| | Cerebral Palsy | 1 | 2016 | 38 | 0.130 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 318 | 0.130 |
Why?
| | Radiography, Abdominal | 1 | 2015 | 25 | 0.120 |
Why?
| | Reference Values | 1 | 2016 | 313 | 0.120 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 952 | 0.120 |
Why?
| | Case-Control Studies | 1 | 2018 | 1202 | 0.110 |
Why?
| | Male | 4 | 2025 | 26863 | 0.110 |
Why?
| | Premature Birth | 1 | 2016 | 150 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 883 | 0.110 |
Why?
| | Child | 1 | 2025 | 7229 | 0.100 |
Why?
| | Time Factors | 2 | 2018 | 3000 | 0.090 |
Why?
| | Myometrium | 1 | 2001 | 14 | 0.090 |
Why?
| | Crossing Over, Genetic | 1 | 2011 | 8 | 0.090 |
Why?
| | Stochastic Processes | 1 | 2011 | 11 | 0.090 |
Why?
| | Normal Distribution | 1 | 2011 | 9 | 0.090 |
Why?
| | Labor, Obstetric | 1 | 2001 | 44 | 0.090 |
Why?
| | Models, Genetic | 1 | 2011 | 172 | 0.080 |
Why?
| | Temperature | 1 | 2011 | 165 | 0.080 |
Why?
| | Parathyroid Hormone | 1 | 2001 | 151 | 0.080 |
Why?
| | Models, Statistical | 1 | 2011 | 231 | 0.080 |
Why?
| | User-Computer Interface | 1 | 2009 | 79 | 0.080 |
Why?
| | Data Interpretation, Statistical | 1 | 2009 | 164 | 0.070 |
Why?
| | Brain Mapping | 1 | 2009 | 226 | 0.070 |
Why?
| | Proteins | 1 | 2001 | 354 | 0.070 |
Why?
| | Pressure | 1 | 2024 | 103 | 0.060 |
Why?
| | Cyanosis | 1 | 2024 | 17 | 0.060 |
Why?
| | Rest | 1 | 2024 | 60 | 0.050 |
Why?
| | Osteoprotegerin | 1 | 2023 | 53 | 0.050 |
Why?
| | Ultrasonography | 1 | 2025 | 424 | 0.050 |
Why?
| | Autonomic Nervous System | 1 | 2023 | 60 | 0.050 |
Why?
| | Cesarean Section | 1 | 2024 | 184 | 0.050 |
Why?
| | Osteoclasts | 1 | 2023 | 428 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2019 | 53 | 0.040 |
Why?
| | Optics and Photonics | 1 | 2017 | 7 | 0.030 |
Why?
| | Megestrol | 1 | 1975 | 1 | 0.030 |
Why?
| | Mestranol | 1 | 1975 | 2 | 0.030 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 1975 | 28 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2017 | 269 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2023 | 2891 | 0.030 |
Why?
| | Mothers | 1 | 2018 | 268 | 0.030 |
Why?
| | Infant | 1 | 2023 | 3720 | 0.030 |
Why?
| | Pituitary Gland | 1 | 1975 | 89 | 0.030 |
Why?
| | Mice | 1 | 2023 | 5958 | 0.030 |
Why?
| | Animals | 4 | 2023 | 13507 | 0.020 |
Why?
| | Isoproterenol | 1 | 2001 | 56 | 0.020 |
Why?
| | Parathyroid Hormone-Related Protein | 1 | 2001 | 24 | 0.020 |
Why?
| | Cyclic AMP | 1 | 2001 | 92 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2001 | 140 | 0.020 |
Why?
| | Estradiol | 1 | 2001 | 216 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2001 | 1378 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2001 | 1588 | 0.020 |
Why?
| | Diphtheria Toxin | 1 | 1975 | 5 | 0.020 |
Why?
| | Digitoxin | 1 | 1975 | 4 | 0.020 |
Why?
| | Hydro-Lyases | 1 | 1975 | 3 | 0.010 |
Why?
| | Cystathionine beta-Synthase | 1 | 1975 | 18 | 0.010 |
Why?
| | Microsomes, Liver | 1 | 1975 | 185 | 0.010 |
Why?
| | Liver | 1 | 1975 | 1160 | 0.010 |
Why?
| | Ovulation | 1 | 1975 | 5 | 0.010 |
Why?
| | Estrus | 1 | 1975 | 15 | 0.010 |
Why?
| | Luteinizing Hormone | 1 | 1975 | 51 | 0.010 |
Why?
| | Follicle Stimulating Hormone | 1 | 1975 | 41 | 0.010 |
Why?
| | Molecular Weight | 2 | 1975 | 80 | 0.010 |
Why?
| | Rats | 2 | 1975 | 3203 | 0.010 |
Why?
| | Cyanogen Bromide | 1 | 1975 | 1 | 0.000 |
Why?
| | Digitoxigenin | 1 | 1975 | 5 | 0.000 |
Why?
| | Chromatography, Thin Layer | 1 | 1975 | 23 | 0.000 |
Why?
| | NADP | 1 | 1975 | 23 | 0.000 |
Why?
| | Hydroxylation | 1 | 1975 | 65 | 0.000 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 1975 | 34 | 0.000 |
Why?
| | Spectrophotometry | 1 | 1975 | 28 | 0.000 |
Why?
| | Sulfhydryl Compounds | 1 | 1975 | 18 | 0.000 |
Why?
| | Peptide Fragments | 1 | 1975 | 210 | 0.000 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1975 | 180 | 0.000 |
Why?
| | Amino Acid Sequence | 1 | 1975 | 574 | 0.000 |
Why?
| | Protein Conformation | 1 | 1975 | 179 | 0.000 |
Why?
| | Chickens | 1 | 1975 | 108 | 0.000 |
Why?
| | Binding Sites | 1 | 1975 | 377 | 0.000 |
Why?
| | Protein Binding | 1 | 1975 | 673 | 0.000 |
Why?
| | Amino Acids | 1 | 1975 | 378 | 0.000 |
Why?
|
|
Escalona-Vargas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|